Works by Eldehna, Wagdy M.


Results: 122
    1
    2
    3
    4
    5
    6

    A multidisciplinary approach to the antioxidant and hepatoprotective activities of Arbutus pavarii Pampan fruit; in vitro and in Vivo biological evaluations, and in silico investigations.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2024, v. 39, n. 1, p. 1, doi. 10.1080/14756366.2023.2293639
    By:
    • Elshibani, Fatma A.;
    • Alamami, Abdullah D.;
    • Mohammed, Hamdoon A.;
    • Rasheed, Rabab Ahmed;
    • El Sabban, Radwa M.;
    • Yehia, Mohamed A.;
    • Abdel Mageed, Sherif S.;
    • Majrashi, Taghreed A.;
    • Elkaeed, Eslam B.;
    • El Hassab, Mahmoud A.;
    • Eldehna, Wagdy M.;
    • El-Ashrey, Mohamed K.
    Publication type:
    Article
    7
    8

    Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2278022
    By:
    • Haffez, Hesham;
    • Elsayed, Nosaiba A.;
    • Ahmed, Marwa F.;
    • Fatahala, Samar S.;
    • Khaleel, Eman F.;
    • Badi, Rehab Mustafa;
    • Elkaeed, Eslam B.;
    • El Hassab, Mahmoud A.;
    • Hammad, Sherif F.;
    • Eldehna, Wagdy M.;
    • Masurier, Nicolas;
    • El-Haggar, Radwan
    Publication type:
    Article
    9
    10

    Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2234665
    By:
    • ElNaggar, Mai H.;
    • Elgazar, Abdullah A.;
    • Gamal, Ghada;
    • Hamed, Shimaa M.;
    • Elsayed, Zainab M.;
    • El-Ashrey, Mohamed K.;
    • Abood, Amira;
    • El Hassab, Mahmoud A.;
    • Soliman, Ahmed M.;
    • El-Domany, Ramadan A.;
    • Badria, Farid A.;
    • Supuran, Claudiu T.;
    • Eldehna, Wagdy M.
    Publication type:
    Article
    11
    12
    13

    Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2202357
    By:
    • Al-Karmalawy, Ahmed A.;
    • El-Gamil, Dalia S.;
    • El-Shesheny, Rabeh;
    • Sharaky, Marwa;
    • Alnajjar, Radwan;
    • Kutkat, Omnia;
    • Moatasim, Yassmin;
    • Elagawany, Mohamed;
    • Al-Rashood, Sara T.;
    • Binjubair, Faizah A.;
    • Eldehna, Wagdy M.;
    • Noreddin, Ayman M.;
    • Zakaria, Mohamed Y.
    Publication type:
    Article
    14

    Identification of new 4-(6-oxopyridazin-1-yl)benzenesulfonamides as multi-target anti-inflammatory agents targeting carbonic anhydrase, COX-2 and 5-LOX enzymes: synthesis, biological evaluations and modelling insights.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2201407
    By:
    • Badawi, Waleed A.;
    • Rashed, Mahmoud;
    • Nocentini, Alessio;
    • Bonardi, Alessandro;
    • Abd-Alhaseeb, Mohammad M.;
    • Al-Rashood, Sara T.;
    • Veerakanellore, Giri Babu;
    • Majrashi, Taghreed A.;
    • Elkaeed, Eslam B.;
    • Elgendy, Bahaa;
    • Gratteri, Paola;
    • Supuran, Claudiu T.;
    • Eldehna, Wagdy M.;
    • Elagawany, Mohamed
    Publication type:
    Article
    15

    Metabolomic profile, anti-trypanosomal potential and molecular docking studies of Thunbergia grandifolia.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2199950
    By:
    • El-Nashar, Heba A. S.;
    • Sayed, Ahmed M.;
    • El-Sherief, Hany A. M.;
    • Rateb, Mostafa E.;
    • Akil, Lina;
    • Khadra, Ibrahim;
    • Majrashi, Taghreed A.;
    • Al-Rashood, Sara T.;
    • Binjubair, Faizah A.;
    • El Hassab, Mahmoud A.;
    • Eldehna, Wagdy M.;
    • Abdelmohsen, Usama Ramadan;
    • Mostafa, Nada M.
    Publication type:
    Article
    16
    17
    18

    Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2171029
    By:
    • Farouk, Faten;
    • Elmaaty, Ayman Abo;
    • Elkamhawy, Ahmed;
    • Tawfik, Haytham O.;
    • Alnajjar, Radwan;
    • Abourehab, Mohammed A. S.;
    • Saleh, Mohamed A.;
    • Eldehna, Wagdy M.;
    • Al‐Karmalawy, Ahmed A.
    Publication type:
    Article
    19

    New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2166036
    By:
    • Al-Sanea, Mohammad M.;
    • Hamdi, Abdelrahman;
    • Mohamed, Ahmed A. B.;
    • El-Shafey, Hamed W.;
    • Moustafa, Mahmoud;
    • Elgazar, Abdullah A.;
    • Eldehna, Wagdy M.;
    • Ur Rahman, Hidayat;
    • Parambi, Della G. T.;
    • Elbargisy, Rehab M.;
    • Selim, Samy;
    • Bukhari, Syed Nasir Abbas;
    • Magdy Hendawy, Omnia;
    • Tawfik, Samar S.
    Publication type:
    Article
    20

    Design and synthesis of novel rigid dibenzo[b,f]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2157825
    By:
    • El-Behairy, Mohammed Farrag;
    • Abd-Allah, Walaa Hamada;
    • Khalifa, Mohamed M.;
    • Nafie, Mohamed S.;
    • Saleh, Mohamed A.;
    • Abdel-Maksoud, Mohammed S.;
    • Al-Warhi, Tarfah;
    • Eldehna, Wagdy M.;
    • Al‐Karmalawy, Ahmed A.
    Publication type:
    Article
    21
    22

    Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR<sup>WT</sup> and EGFR<sup>T790M</sup> inhibitors.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 176, doi. 10.1080/14756366.2022.2135512
    By:
    • Al-Warhi, Tarfah;
    • Al-Karmalawy, Ahmed A.;
    • Elmaaty, Ayman Abo;
    • Alshubramy, Maha A.;
    • Abdel-Motaal, Marwa;
    • Majrashi, Taghreed A.;
    • Asem, Medhat;
    • Nabil, Ahmed;
    • Eldehna, Wagdy M.;
    • Sharaky, Marwa
    Publication type:
    Article
    23
    24
    25

    New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 2191, doi. 10.1080/14756366.2022.2110869
    By:
    • Elkaeed, Eslam B.;
    • Taghour, Mohammed S.;
    • Mahdy, Hazem A.;
    • Eldehna, Wagdy M.;
    • El-Deeb, Nehal M.;
    • Kenawy, Ahmed M.;
    • Alsfouk, Bshra A.;
    • Dahab, Mohammed A.;
    • Metwaly, Ahmed M.;
    • Eissa, Ibrahim H.;
    • El-Zahabi, Mohamed A.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32

    Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 2265, doi. 10.1080/14756366.2022.2104841
    By:
    • Abdelsalam, Esraa A.;
    • Abd El-Hafeez, Amer Ali;
    • Eldehna, Wagdy M.;
    • El Hassab, Mahmoud A.;
    • Marzouk, Hala Mohamed M.;
    • Elaasser, Mahmoud M.;
    • Abou Taleb, Nageh A.;
    • Amin, Kamilia M.;
    • Abdel-Aziz, Hatem A.;
    • Ghosh, Pradipta;
    • Hammad, Sherif F.
    Publication type:
    Article
    33

    Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1389, doi. 10.1080/14756366.2022.2070744
    By:
    • Yousef, Reda G.;
    • Ibrahim, Albaraa;
    • Khalifa, Mohamed M.;
    • Eldehna, Wagdy M.;
    • Gobaara, Ibraheem M. M.;
    • Mehany, Ahmed B. M.;
    • Elkaeed, Eslam B.;
    • Alsfouk, Aisha A.;
    • Metwaly, Ahmed M.;
    • Eissa, Ibrahim H.
    Publication type:
    Article
    34

    Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 531, doi. 10.1080/14756366.2021.2024528
    By:
    • Eldehna, Wagdy M.;
    • Taghour, Mohammed S.;
    • Al-Warhi, Tarfah;
    • Nocentini, Alessio;
    • Elbadawi, Mostafa M.;
    • Mahdy, Hazem A.;
    • Abdelrahman, Mohamed A.;
    • Alotaibi, Ohoud J.;
    • Aljaeed, Nada;
    • Elimam, Diaaeldin M.;
    • Afarinkia, Kamyar;
    • Abdel-Aziz, Hatem A.;
    • Supuran, Claudiu T.
    Publication type:
    Article
    35

    Design and synthesis of thiazolidine-2/4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1903, doi. 10.1080/14756366.2022.2085693
    By:
    • Taghour, Mohammed S.;
    • Elkady, Hazem;
    • Eldehna, Wagdy M.;
    • El-Deeb, Nehal M.;
    • Kenawy, Ahmed M.;
    • Elkaeed, Eslam B.;
    • Alsfouk, Aisha A.;
    • Alesawy, Mohamed S.;
    • Metwaly, Ahmed M.;
    • Eissa, Ibrahim. H.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Novel [(N-alkyl-3-indolylmethylene)hydrazono]oxindoles arrest cell cycle and induce cell apoptosis by inhibiting CDK2 and Bcl-2: synthesis, biological evaluation and in silico studies.

    Published in:
    Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 1300, doi. 10.1080/14756366.2020.1773814
    By:
    • Al-Warhi, Tarfah;
    • Abo-Ashour, Mahmoud F.;
    • Almahli, Hadia;
    • Alotaibi, Ohoud J.;
    • Al-Sanea, Mohammad M.;
    • Al-Ansary, Ghada H.;
    • Ahmed, Hanaa Y.;
    • Elaasser, Mahmoud M.;
    • Eldehna, Wagdy M.;
    • Abdel-Aziz, Hatem A.
    Publication type:
    Article
    47
    48
    49
    50